Bill Snyder Archive — Page 38 of 119
-
September 16, 2021
VUMC team to test personalized acute heart failure treatment
Researchers at Vanderbilt have been awarded a five-year, $4 million federal grant to test whether a personalized medicine strategy will improve outcomes for patients hospitalized with acute heart failure. -
September 16, 2021
Chung receives early investigator award from ASCPT
Vanderbilt's Cecilia Chung, MD, MPH, has received the 2022 Leon I. Goldberg Early Investigator Award from the American Society of Clinical Pharmacology and Therapeutics (ASCPT). -
September 16, 2021
‘Pre-conditioning’ restores immune tolerance
A treatment targeting T-cell metabolism could reinvigorate immune tolerance mechanisms to combat autoimmune disease and transplant rejection, Vanderbilt researchers discovered. -
September 8, 2021
VUMC antibodies help neutralize two deadly viruses: study
Vanderbilt researchers have isolated monoclonal antibodies that prevent severe illness and death caused by two emerging and deadly viruses called Nipah and Hendra. -
September 2, 2021
Discovery offers insight for development of cancer therapies targeting mutant p53
Vanderbilt researchers have discovered that aneuploidy (an abnormal number of chromosomes) drives malignant phenotypes in cells expressing mutant p53, a tumor suppressor protein that is mutated in more than half of all human cancers. -
September 2, 2021
A leading authority in ICU-related depression and PTSD, Jim Jackson’s skills have proven especially critical to helping patients during the pandemic
"The last year has been so traumatizing and hard, but to use the skills and knowledge that we have been developing to good effect in the service of others during this difficult season has been meaningful.”